| Utestående aktier | 70,943,689 shares |
| Insideraktier | 25 710 234 shares |
| Insynsägande | 36,24 % |
| Totalt antal insynspersoner | 30 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
-0.004 %( )
9785 out of 11218Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Phathom Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Steven L Basta President and CEO, Director - [D] [O] | 0 | 0 | |
| Branning Todd P. | 0 | ||
| Robert Charles Breedlove Principal Accounting Officer - [O] | 47 931 | 47 931 | |
| Michael F Cola Director - [D] | 39 798 | 39 798 | |
| Anne Marie Cook Chief Legal Off. & Corp. Sec. - [O] | 0 | 0 | |
| Terrie Curran President and Chief Executive, Director - [D] [O] | 360 465 | 360 465 | |
| Edwards Jonathan S. Director - [D] | 47 984 | 47 984 | |
|
Fhmls Ix, L.l.c.
10% Owner -
|
5 827 415 | 5 827 415 | |
|
Fhmls Ix, L.p.
10% Owner -
|
5 827 415 | 5 827 415 | |
| Heidi Fields Director - [D] | 30 000 | 30 000 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Frazier Life Sciences IX, L.P.
10% Owner -
|
5 827 415 | 5 827 415 | |
| Guzzo Anthony J. VP, Chief Accounting Officer - [O] | 8 399 | 8 399 | |
| Molly Henderson CFO and CBO - [O] | 89 868 | 89 868 | |
|
Patrick J Heron
10% Owner -
|
5 827 415 | 5 827 415 | |
| Frank Karbe Director - [D] | 67 500 | 67 500 | |
| Aditya Kohli Chief Business Officer - [O] | 1 686 704 | 1 686 704 | |
|
Peter Kolchinsky
10% Owner -
|
3 115 008 | 3 115 008 | |
|
Ventures Management (Jersey) Ltd Medicxi
10% Owner -
|
61 975 | 61 975 | |
| Azmi Nabulsi Chief Operating Officer - [O] | 1 101 869 | 1 101 869 | |
| Asit Parikh Director - [D] | 113 500 | 113 500 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Ra Capital Management, Llc
10% Owner -
|
3 115 008 | 3 115 008 | |
|
RA Capital Healthcare Fund LP
10% Owner -
|
3 115 008 | 3 115 008 | |
| Theodore R Schroeder Director - [D] | 0 | 0 | |
|
Shah Rajeev M.
10% Owner -
|
3 115 008 | 3 115 008 | |
| Slavinsky Christopher W. | 0 | ||
| David A Socks Director - [D] | 19 500 | 19 500 | |
| Mark Stenhouse Director - [D] | 30 000 | 30 000 | |
|
Pharmaceutical Co Ltd Takeda
10% Owner -
|
3 755 583 | 3 755 583 | |
|
James N Topper
Director, 10% Owner -
[D]
|
5 933 327 | 5 933 327 | |
|
Tadataka Yamada
Director, 10% Owner -
[D]
|
3 373 408 | 3 373 408 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PHAT / Phathom Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PHAT / Phathom Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-09 | 2025-09-05 | 4 | Breedlove Robert Charles | PHAT | Common Stock | D | 12,0900 | −461 | −6 | 47 931 | ||||
| 2025-07-18 | 2025-07-16 | 4 | Breedlove Robert Charles | PHAT | Common Stock | D | 8,3639 | −1 692 | −14 | 48 392 | ||||
| 2025-06-24 | 3 | Cook Anne Marie | PHAT | No securities are beneficially owned. | D | 0 | ||||||||
| 2025-06-05 | 2025-06-03 | 4 | KARBE FRANK | PHAT | Common Stock | D | 10 500 | 67 500 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 10 500 | 39 798 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | FIELDS HEIDI | PHAT | Common Stock | D | 10 500 | 30 000 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | Topper James N | PHAT | Common Stock | D | 10 500 | 42 596 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | Parikh Asit | PHAT | Common Stock | D | 10 500 | 113 500 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | Stenhouse Mark | PHAT | Common Stock | D | 10 500 | 30 000 | ||||||
| 2025-05-23 | 2025-05-21 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,8649 | 3 780 | 15 | 59 403 | ||||
| 2025-05-15 | 2025-05-14 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,3205 | 6 300 | 21 | 55 623 | ||||
| 2025-05-15 | 2025-05-13 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,1637 | 1 120 | 4 | 49 323 | ||||
| 2025-05-13 | 2025-05-12 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,0395 | 12 601 | 38 | 48 203 | ||||
| 2025-05-13 | 2025-05-09 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,6177 | 2 226 | 8 | 35 602 | ||||
| 2025-05-13 | 2025-05-09 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,1928 | 33 376 | 107 | 33 376 | ||||
| 2025-05-08 | 2025-05-07 | 4 | Parikh Asit | PHAT | Common Stock | D | 2,3969 | 5 000 | 12 | 95 500 | ||||
| 2025-05-08 | 2025-05-06 | 4 | Parikh Asit | PHAT | Common Stock | D | 2,6000 | 5 000 | 13 | 90 500 | ||||
| 2025-05-06 | 3 | Breedlove Robert Charles | PHAT | Common Stock | D | 50 084 | ||||||||
| 2025-05-06 | 3 | Breedlove Robert Charles By 401(k) | PHAT | Common Stock | I | 5 108 | ||||||||
| 2025-04-16 | 2025-04-16 | 4 | Schroeder Theodore R | PHAT | Common Stock | D | 21 000 | 21 000 | ||||||
| 2025-04-16 | 3 | Schroeder Theodore R | PHAT | No securities are beneficially owned. | D | 0 | ||||||||
| 2025-04-08 | 2025-04-07 | 4 | Henderson Molly | PHAT | Common Stock | D | 4,5513 | −3 678 | −17 | 89 868 | ||||
| 2025-04-03 | 3 | Basta Steven L | PHAT | No securities are beneficially owned. | D | 0 | ||||||||
| 2025-03-21 | 2024-09-10 | 4 | Parikh Asit | PHAT | Common Stock | D | 11,7200 | 7 500 | 88 | 93 000 | ||||
| 2025-03-17 | 2025-03-13 | 4 | Parikh Asit | PHAT | Common Stock | D | 4,4200 | 10 000 | 44 | 85 500 | ||||
| 2025-03-03 | 2025-02-27 | 4 | Henderson Molly | PHAT | Common Stock | D | 72 000 | 165 546 | ||||||
| 2025-03-03 | 2025-02-27 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 79 200 | 312 590 | ||||||
| 2025-01-23 | 2025-01-21 | 4 | Henderson Molly | PHAT | Common Stock | D | 6,5883 | −6 583 | −43 | 93 546 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 6,5885 | −7 886 | −52 | 233 390 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Curran Terrie | PHAT | Common Stock | D | 6,5877 | −19 109 | −126 | 360 465 | ||||
| 2024-12-20 | 2024-12-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 8,0000 | −1 118 | −9 | 239 303 | ||||
| 2024-12-20 | 2024-12-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 8,0000 | −1 291 | −10 | 98 156 | ||||
| 2024-12-16 | 2024-12-13 | 4 | Parikh Asit | PHAT | Common Stock | D | 8,1248 | 10 000 | 81 | 75 500 | ||||
| 2024-12-16 | 2024-12-13 | 4 | KARBE FRANK | PHAT | Common Stock | D | 7,9267 | 12 500 | 99 | 57 000 | ||||
| 2024-07-17 | 2024-07-15 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 11,7200 | −10 901 | −128 | 240 421 | ||||
| 2024-07-17 | 2024-07-15 | 4 | Henderson Molly | PHAT | Common Stock | D | 11,7200 | −4 325 | −51 | 99 447 | ||||
| 2024-07-17 | 2024-07-15 | 4 | Curran Terrie | PHAT | Common Stock | D | 11,7200 | −33 848 | −397 | 377 734 | ||||
| 2024-05-31 | 2024-05-31 | 4 | Henderson Molly | PHAT | Common Stoock | D | 7 500 | 102 763 | ||||||
| 2024-05-31 | 2024-05-31 | 4 | Nabulsi Azmi | PHAT | Common Stoock | D | 7 500 | 249 567 | ||||||
| 2024-05-31 | 2024-05-29 | 4 | KARBE FRANK | PHAT | Common Stock | D | 10,1645 | 25 000 | 254 | 44 500 | ||||
| 2024-05-24 | 2024-05-23 | 4 | Topper James N | PHAT | Common Stock | D | 10 500 | 32 096 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | Parikh Asit | PHAT | Common Stock | D | 10 500 | 65 500 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 10 500 | 29 298 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | FIELDS HEIDI | PHAT | Common Stock | D | 10 500 | 19 500 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | KARBE FRANK | PHAT | Common Stock | D | 10 500 | 19 500 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | Stenhouse Mark | PHAT | Common Stock | D | 10 500 | 19 500 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | Socks David A | PHAT | Common Stock | D | 10 500 | 19 500 | ||||||
| 2024-04-10 | 2024-04-08 | 4 | Henderson Molly | PHAT | Common Stoock | D | 11,1000 | −3 435 | −38 | 95 263 | ||||
| 2024-03-26 | 2024-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 9,1100 | −16 851 | −154 | 410 784 | ||||
| 2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi IV LP | PHAT | Common Stock | I | 3 641 728 | ||||||||
| 2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi Growth I LP | PHAT | Common Stock | I | 3 673 602 | ||||||||
| 2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi Co-Invest IV LP | PHAT | Common Stock | I | 61 975 | ||||||||
| 2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi Growth Co-Invest I LP | PHAT | Common Stock | I | 87 267 | ||||||||
| 2024-01-25 | 2024-01-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 8,1000 | −3 703 703 | −30 000 | 3 755 583 | ||||
| 2024-01-22 | 2024-01-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,7533 | −6 307 | −49 | 98 698 | ||||
| 2023-11-21 | 2023-11-20 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,2415 | −2 127 | −15 | 103 061 | ||||
| 2023-11-08 | 2023-11-08 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,8000 | 2 500 | 20 | 55 000 | ||||
| 2023-11-08 | 2023-11-07 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,7600 | 4 000 | 31 | 52 500 | ||||
| 2023-11-08 | 2023-11-06 | 4 | Parikh Asit | PHAT | Common Stock | D | 8,0400 | 1 000 | 8 | 48 500 | ||||
| 2023-11-03 | 2023-11-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 8,9500 | −11 681 | −105 | 105 188 | ||||
| 2023-11-03 | 2023-11-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,8000 | −811 | −6 | 116 869 | ||||
| 2023-11-03 | 2023-11-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 22 500 | 117 680 | ||||||
| 2023-11-03 | 2023-11-01 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 32 500 | 242 067 | ||||||
| 2023-11-03 | 2023-11-01 | 4 | Curran Terrie | PHAT | Common Stock | D | 37 500 | 427 171 | ||||||
| 2023-07-21 | 2023-07-14 | 4/A | Henderson Molly | PHAT | Common Stock | D | 25 000 | 95 180 | ||||||
| 2023-07-17 | 2023-07-14 | 4 | Henderson Molly | PHAT | Common Stock | D | 1,0000 | 25 000 | 25 | 95 180 | ||||
| 2023-07-17 | 2023-07-14 | 4 | Curran Terrie | PHAT | Common Stock | D | 200 000 | 389 671 | ||||||
| 2023-07-17 | 2023-07-14 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 110 000 | 209 567 | ||||||
| 2023-06-05 | 2023-06-02 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,4000 | 15 000 | 111 | 47 500 | ||||
| 2023-06-05 | 2023-06-02 | 4 | Henderson Molly | PHAT | Common Stock | D | 11,4121 | −1 960 | −22 | 68 506 | ||||
| 2023-05-30 | 2023-05-25 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 9 000 | 18 798 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | Stenhouse Mark | PHAT | Common Stock | D | 9 000 | 9 000 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | Socks David A | PHAT | Common Stock | D | 9 000 | 9 000 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | Parikh Asit | PHAT | Common Stock | D | 9 000 | 32 500 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | FIELDS HEIDI | PHAT | Common Stock | D | 9 000 | 9 000 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | KARBE FRANK | PHAT | Common Stock | D | 9 000 | 9 000 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | Topper James N | PHAT | Common Stock | D | 9 000 | 21 596 | ||||||
| 2023-05-23 | 2023-05-22 | 4 | Henderson Molly | PHAT | Common Stock | D | 12,8744 | −2 110 | −27 | 70 466 | ||||
| 2023-04-11 | 2023-04-11 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 8,2600 | 10 000 | 83 | 99 567 | ||||
| 2023-04-11 | 2023-04-10 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,5500 | 1 000 | 8 | 23 500 | ||||
| 2023-04-07 | 2023-04-06 | 4 | Curran Terrie | PHAT | Common Stock | D | 7,8199 | 12 919 | 101 | 188 290 | ||||
| 2023-04-07 | 2023-04-06 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,2700 | −3 439 | −25 | 72 576 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 8,5309 | −2 032 | −17 | 76 015 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Curran Terrie | PHAT | Common Stock | D | 8,5411 | −1 436 | −12 | 175 371 | ||||
| 2023-02-14 | 2023-02-13 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,7320 | 5 000 | 39 | 22 500 | ||||
| 2023-01-20 | 2023-01-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 45 000 | 89 567 | ||||||
| 2023-01-20 | 2023-01-20 | 4 | Curran Terrie | PHAT | Common Stock | D | 8,1995 | −5 821 | −48 | 176 807 | ||||
| 2023-01-20 | 2023-01-19 | 4 | Curran Terrie | PHAT | Common Stock | D | 97 500 | 182 628 | ||||||
| 2023-01-20 | 2023-01-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 33 000 | 78 047 | ||||||
| 2023-01-12 | 2023-01-12 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,0000 | 5 000 | 35 | 17 500 | ||||
| 2022-11-23 | 2022-11-21 | 4 | Curran Terrie | PHAT | Common Stock | D | 9,6000 | −1 526 | −15 | 83 720 | ||||
| 2022-11-23 | 2022-11-21 | 4 | Henderson Molly | PHAT | Common Stock | D | 9,6000 | −2 159 | −21 | 43 341 | ||||
| 2022-09-02 | 2022-09-01 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 7 500 | 41 971 | ||||||
| 2022-09-02 | 2022-09-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 7 500 | 45 500 | ||||||
| 2022-09-02 | 2022-09-01 | 4 | Curran Terrie | PHAT | Common Stock | D | 7 500 | 85 246 | ||||||
| 2022-05-27 | 2022-05-25 | 4 | COLA MICHAEL F | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | Stenhouse Mark | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | FIELDS HEIDI | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | Socks David A | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | Parikh Asit | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | KARBE FRANK | PHAT | Stock Option (Right to Buy) | D | 7,40 | 10 000 | 10 000 | |||||
| 2022-05-20 | 2022-05-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 12 000 | 33 378 | ||||||
| 2022-05-20 | 2022-05-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 12 000 | 38 000 | ||||||
| 2022-05-20 | 2022-05-19 | 4 | Curran Terrie | PHAT | Common Stock | D | 12 000 | 76 595 | ||||||
| 2022-05-16 | 2022-05-16 | 4 | Nabulsi Azmi by Trust | PHAT | Common Stock | I | 8,1644 | 20 000 | 163 | 785 700 | ||||
| 2022-05-16 | 2022-05-13 | 4 | Curran Terrie | PHAT | Common Stock | D | 7,4066 | 20 500 | 152 | 64 595 | ||||
| 2022-05-16 | 2022-05-13 | 4 | Henderson Molly | PHAT | Common Stock | D | 6 000 | 26 000 | ||||||
| 2022-05-16 | 2022-05-12 | 4 | Parikh Asit | PHAT | Common Stock | D | 8,0000 | 12 500 | 100 | 12 500 | ||||
| 2022-04-26 | 2022-04-25 | 4 | KARBE FRANK | PHAT | Stock Option (Right to Buy) | D | 13,61 | 20 000 | 20 000 | |||||
| 2022-04-06 | 2022-04-05 | 4 | Henderson Molly | PHAT | Stock Option (Right to Buy) | D | 15,08 | 100 000 | 100 000 | |||||
| 2022-04-06 | 2022-04-05 | 4 | Henderson Molly | PHAT | Common Stock | D | 20 000 | 20 000 | ||||||
| 2022-03-16 | 2022-03-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Warrants | D | 0,00 | −7 359 304 | 0 | |||||
| 2022-03-16 | 2022-03-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 19,0000 | −18 | −0 | 7 459 286 | ||||
| 2022-03-16 | 2022-03-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 7 359 304 | 7 459 304 | ||||||
| 2022-02-18 | 2019-10-29 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 19,0000 | 9 798 | 186 | 9 798 | ||||
| 2022-01-21 | 2022-01-19 | 4 | Nabulsi Azmi | PHAT | Stock Option (Right to Buy) | D | 15,21 | 97 500 | 97 500 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 19 500 | 21 378 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Guzzo Anthony J. | PHAT | Stock Option (Right to Buy) | D | 15,21 | 30 000 | 30 000 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Guzzo Anthony J. | PHAT | Common Stock | D | 6 000 | 8 399 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 15,21 | 206 250 | 206 250 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Curran Terrie | PHAT | Common Stock | D | 41 250 | 44 095 | ||||||
| 2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Warrants | D | 0,00 | −228 696 | 7 359 304 | |||||
| 2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 20,8500 | −1 000 000 | −20 850 | 100 000 | ||||
| 2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 19,0000 | −1 | −0 | 1 100 000 | ||||
| 2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 228 696 | 1 100 001 | ||||||
| 2021-10-08 | 2021-10-08 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,0490 | −2 529 | −81 | 1 211 346 | ||||
| 2021-10-08 | 2021-10-07 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,6639 | −15 471 | −505 | 1 213 875 | ||||
| 2021-09-23 | 2021-09-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,0600 | −4 100 | −131 | 1 229 346 | ||||
| 2021-09-23 | 2021-09-21 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 33,3058 | −324 | −11 | 1 233 446 | ||||
| 2021-09-23 | 2021-09-21 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,7868 | −13 576 | −445 | 1 233 770 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 31,4907 | −13 791 | −434 | 1 247 346 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 30,4704 | −4 209 | −128 | 1 261 137 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Parikh Asit | PHAT | Stock Option (Right to Buy) | D | 34,05 | 7 500 | 7 500 | |||||
| 2021-07-09 | 2021-07-07 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0500 | −2 609 | −91 | 871 305 | ||||
| 2021-07-06 | 2021-07-02 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0100 | −100 | −4 | 873 914 | ||||
| 2021-07-06 | 2021-07-01 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1600 | −8 226 | −289 | 874 014 | ||||
| 2021-06-29 | 2021-06-29 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,0012 | −13 960 | −475 | 1 260 945 | ||||
| 2021-06-29 | 2021-06-28 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,0869 | −156 | −5 | 1 274 905 | ||||
| 2021-06-29 | 2021-06-28 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,0678 | −25 884 | −882 | 1 275 061 | ||||
| 2021-06-29 | 2021-06-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0800 | −370 | −13 | 882 240 | ||||
| 2021-06-29 | 2021-06-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,0700 | −1 250 | −45 | 882 610 | ||||
| 2021-06-29 | 2021-06-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,4600 | −22 881 | −811 | 883 860 | ||||
| 2021-06-25 | 2021-06-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1400 | −10 848 | −381 | 906 741 | ||||
| 2021-06-25 | 2021-06-23 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | −200 | −7 | 917 589 | ||||
| 2021-06-23 | 2021-06-22 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | −100 | −4 | 917 789 | ||||
| 2021-06-23 | 2021-06-21 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3100 | −9 294 | −328 | 917 889 | ||||
| 2021-06-21 | 2021-06-18 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1300 | −5 398 | −190 | 927 183 | ||||
| 2021-06-21 | 2021-06-17 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0800 | −3 305 | −116 | 932 581 | ||||
| 2021-06-16 | 2021-06-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0600 | −2 826 | −99 | 935 886 | ||||
| 2021-06-11 | 3 | Guzzo Anthony J. | PHAT | Common Stock | D | 804 | ||||||||
| 2021-06-11 | 2021-06-10 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1400 | −2 102 | −74 | 938 712 | ||||
| 2021-06-11 | 2021-06-09 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,2800 | −1 191 | −42 | 940 814 | ||||
| 2021-06-09 | 2021-06-08 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | −100 | −4 | 942 005 | ||||
| 2021-06-09 | 2021-06-07 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0500 | −2 264 | −79 | 942 105 | ||||
| 2021-06-04 | 2021-06-02 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1800 | −4 300 | −151 | 944 369 | ||||
| 2021-06-02 | 2021-06-01 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,2000 | −3 967 | −144 | 948 669 | ||||
| 2021-06-02 | 2021-06-01 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,5500 | −7 244 | −258 | 952 636 | ||||
| 2021-06-02 | 2021-05-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,5500 | −2 104 | −79 | 959 880 | ||||
| 2021-06-02 | 2021-05-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,4000 | −2 668 | −97 | 961 984 | ||||
| 2021-06-02 | 2021-05-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3700 | −4 133 | −146 | 964 652 | ||||
| 2021-05-28 | 2021-05-27 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,5500 | −2 279 | −86 | 968 785 | ||||
| 2021-05-28 | 2021-05-27 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,9900 | −6 174 | −228 | 971 064 | ||||
| 2021-05-28 | 2021-05-26 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,9200 | −4 889 | −181 | 977 238 | ||||
| 2021-05-28 | 2021-05-26 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,4500 | −7 469 | −272 | 982 127 | ||||
| 2021-05-26 | 2021-05-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,5900 | −548 | −20 | 989 596 | ||||
| 2021-05-26 | 2021-05-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,1600 | −10 399 | −376 | 990 144 | ||||
| 2021-05-26 | 2021-05-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,1000 | −1 683 | −61 | 1 000 543 | ||||
| 2021-05-26 | 2021-05-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,5800 | −8 911 | −317 | 1 002 226 | ||||
| 2021-05-24 | 2021-05-21 | 4 | Yamada Tadataka | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | Socks David A | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | COLA MICHAEL F | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | Stenhouse Mark | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | Parikh Asit | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | FIELDS HEIDI | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,7400 | −11 648 | −416 | 1 011 137 | ||||
| 2021-05-24 | 2021-05-20 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1000 | −7 098 | −249 | 1 022 785 | ||||
| 2021-05-21 | 2021-05-20 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,2662 | −305 | −11 | 1 300 945 | ||||
| 2021-05-21 | 2021-05-20 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,9340 | −2 278 | −80 | 1 301 250 | ||||
| 2021-05-21 | 2021-05-20 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 33,7606 | −899 | −30 | 1 303 528 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 33,3796 | −3 229 | −108 | 1 304 427 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,7836 | −16 020 | −525 | 1 307 656 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 31,9557 | −17 269 | −552 | 1 323 676 | ||||
| 2021-05-18 | 2021-05-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | −100 | −4 | 1 029 883 | ||||
| 2021-05-14 | 2021-05-13 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3300 | −100 | −4 | 1 029 983 | ||||
| 2021-05-14 | 2021-05-12 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,0600 | −905 | −33 | 1 030 083 | ||||
| 2021-05-14 | 2021-05-12 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3900 | −10 871 | −385 | 1 030 988 | ||||
| 2021-05-11 | 2021-05-07 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0300 | −1 011 | −35 | 1 041 859 | ||||
| 2021-05-07 | 2021-05-06 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0100 | −202 | −7 | 1 042 870 | ||||
| 2021-05-07 | 2021-05-05 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1400 | −6 936 | −244 | 1 043 072 | ||||
| 2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 38,5300 | −100 | −4 | 1 050 008 | ||||
| 2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,4700 | −3 500 | −131 | 1 050 108 | ||||
| 2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,2100 | −4 690 | −170 | 1 053 608 | ||||
| 2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,5000 | −11 070 | −393 | 1 058 298 | ||||
| 2021-05-05 | 2021-05-03 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 39,0600 | −203 | −8 | 1 069 368 | ||||
| 2021-05-05 | 2021-05-03 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 38,4500 | −11 272 | −433 | 1 069 571 | ||||
| 2021-05-05 | 2021-05-03 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,6000 | −3 157 | −119 | 1 080 843 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,8609 | −1 089 | −41 | 765 700 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,0866 | −1 400 | −52 | 766 789 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 36,1535 | −1 968 | −71 | 768 189 | ||||
| 2021-05-04 | 2021-05-03 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 38,5876 | −5 753 | −222 | 770 157 | ||||
| 2021-05-04 | 2021-05-03 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,8461 | −4 290 | −162 | 775 910 | ||||
| 2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 38,0302 | −6 795 | −258 | 1 340 945 | ||||
| 2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 37,3738 | −6 328 | −237 | 1 347 740 | ||||
| 2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,9698 | −3 359 | −121 | 1 354 068 | ||||
| 2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,9605 | −1 400 | −49 | 1 357 427 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 37,1532 | −1 730 | −64 | 1 358 827 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 36,4002 | −7 769 | −283 | 1 360 557 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,6872 | −12 619 | −450 | 1 368 326 | ||||
| 2021-04-05 | 2021-04-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,1131 | −785 | −29 | 780 200 | ||||
| 2021-04-05 | 2021-04-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 36,3656 | −4 316 | −157 | 780 985 | ||||
| 2021-04-05 | 2021-04-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 35,6645 | −4 252 | −152 | 785 301 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 38,1411 | −1 742 | −66 | 789 553 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,2766 | −3 405 | −127 | 791 295 | ||||
| 2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 6,95 | −11 513 | 855 687 | |||||
| 2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 44,0838 | −1 140 | −50 | 0 | ||||
| 2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 43,2368 | −10 373 | −448 | 1 140 | ||||
| 2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 6,9500 | 11 513 | 80 | 11 513 | ||||
| 2021-03-15 | 2021-03-11 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 43,7500 | −710 000 | −31 062 | 3 115 008 | ||||
| 2021-03-12 | 2021-03-12 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,6700 | −500 | −23 | 1 380 945 | ||||
| 2021-03-12 | 2021-03-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,5367 | −731 | −35 | 1 381 445 | ||||
| 2021-03-12 | 2021-03-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,1809 | −41 698 | −1 967 | 1 382 176 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 49,9303 | −1 802 | −90 | 1 423 874 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 49,0203 | −7 844 | −385 | 1 425 676 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 48,3163 | −2 425 | −117 | 1 433 520 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,2293 | −2 070 | −96 | 794 700 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,1722 | −1 600 | −72 | 796 770 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,7300 | −24 | −1 | 798 370 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,1576 | −4 833 | −223 | 798 394 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 44,5950 | −600 | −27 | 803 227 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,0549 | −1 548 | −71 | 803 827 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,7696 | −3 825 | −175 | 805 375 | ||||
| 2021-02-23 | 2021-02-23 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 44,6967 | −2 084 | −93 | 1 435 945 | ||||
| 2021-02-23 | 2021-02-23 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 43,3461 | −1 881 | −82 | 1 438 029 | ||||
| 2021-02-23 | 2021-02-23 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,5018 | −1 019 | −43 | 1 439 910 | ||||
| 2021-02-23 | 2021-02-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,9901 | −1 417 | −67 | 1 440 929 | ||||
| 2021-02-23 | 2021-02-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,0250 | −7 241 | −333 | 1 442 346 | ||||
| 2021-02-23 | 2021-02-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 45,2652 | −11 482 | −520 | 1 449 587 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,6100 | −18 316 | −872 | 1 461 069 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,0834 | −21 360 | −1 006 | 1 479 385 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,0207 | −5 200 | −239 | 1 500 745 | ||||
| 2021-02-12 | 2020-12-01 | 5 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | −27 000 | 1 505 945 | ||||||
| 2021-02-03 | 2021-02-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 41,1626 | −6 384 | −263 | 809 200 | ||||
| 2021-02-03 | 2021-02-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 40,5087 | −2 700 | −109 | 815 584 | ||||
| 2021-02-03 | 2021-02-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 38,0881 | −5 416 | −206 | 818 284 | ||||
| 2021-01-29 | 2021-01-28 | 4 | Nabulsi Azmi | PHAT | Stock Option (Right to Buy) | D | 39,11 | 150 000 | 150 000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Branning Todd P. | PHAT | Stock Option (Right to Buy) | D | 39,11 | 60 000 | 60 000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 39,11 | 225 000 | 225 000 | |||||
| 2021-01-13 | 2021-01-12 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 36,1845 | −20 091 | −727 | 1 532 945 | ||||
| 2021-01-13 | 2021-01-12 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,7382 | −7 074 | −253 | 1 553 036 | ||||
| 2021-01-13 | 2021-01-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,9235 | −12 835 | −448 | 1 560 110 | ||||
| 2021-01-05 | 2020-01-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 33,7694 | −1 854 | −63 | 823 700 | ||||
| 2021-01-05 | 2020-01-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 34,5700 | −100 | −3 | 825 554 | ||||
| 2021-01-05 | 2020-01-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 33,9332 | −7 614 | −258 | 825 654 | ||||
| 2021-01-05 | 2020-01-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 33,0174 | −4 932 | −163 | 833 268 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,0000 | −100 | −4 | 1 572 945 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 41,4302 | −12 915 | −535 | 1 573 045 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 40,4894 | −35 197 | −1 425 | 1 585 960 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 48,9900 | −200 | −10 | 1 621 157 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 48,1900 | −12 954 | −624 | 1 621 357 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,3492 | −13 292 | −629 | 1 634 311 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,2205 | −5 000 | −231 | 1 647 603 | ||||
| 2020-12-03 | 2020-12-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,5700 | −2 995 | −136 | 838 200 | ||||
| 2020-12-03 | 2020-12-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,0500 | −4 307 | −194 | 841 195 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 44,8300 | −1 828 | −82 | 845 502 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 43,9900 | −5 370 | −236 | 847 330 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 40,3605 | −903 | −36 | 1 652 603 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 39,2240 | −3 354 | −132 | 1 653 506 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 38,1747 | −2 620 | −100 | 1 656 860 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 43,0700 | −200 | −9 | 1 659 480 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,3114 | −4 601 | −195 | 1 664 081 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 41,2923 | −7 880 | −325 | 1 668 682 | ||||
| 2020-11-12 | 2020-11-09 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 44,0000 | −100 | −4 | 1 676 562 | ||||
| 2020-11-12 | 2020-11-09 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,6663 | −5 477 | −234 | 1 676 662 | ||||
| 2020-11-12 | 2020-11-09 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 41,9478 | −5 207 | −218 | 1 682 139 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 36,8294 | −14 500 | −534 | 852 700 | ||||
| 2020-11-03 | 2020-06-25 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 867 200 | 867 200 | ||||||
| 2020-11-03 | 2020-06-25 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | −867 200 | 0 | ||||||
| 2020-07-13 | 2020-07-13 | 4 | Branning Todd P. | PHAT | Stock Option (Right to Buy) | D | 29,43 | 85 000 | 85 000 | |||||
| 2020-07-02 | 2020-07-01 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 32,20 | 175 000 | 175 000 | |||||
| 2020-07-02 | 2020-07-01 | 4 | Nabulsi Azmi | PHAT | Stock Option (Right to Buy) | D | 32,20 | 70 000 | 70 000 | |||||
| 2020-06-16 | 2020-06-12 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Common Stock | D | −1 456 854 | 5 827 415 | ||||||
| 2020-05-22 | 2020-05-21 | 4 | FIELDS HEIDI | PHAT | Stock Options | D | 36,85 | 10 000 | 10 000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Topper James N | PHAT | Stock Option | D | 36,85 | 10 000 | 10 000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Yamada Tadataka | PHAT | Stock Option | D | 36,85 | 10 000 | 10 000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | COLA MICHAEL F | PHAT | Stock Option | D | 36,85 | 10 000 | 10 000 | |||||
| 2020-04-03 | 2020-04-01 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 24,8609 | 117 600 | 2 924 | 3 825 008 | ||||
| 2020-03-31 | 2020-03-31 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 24,5511 | 30 600 | 751 | 3 707 408 | ||||
| 2020-03-31 | 2020-03-27 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 24,6000 | 30 000 | 738 | 3 676 808 | ||||
| 2020-03-19 | 2020-03-17 | 4 | Stenhouse Mark | PHAT | Stock Option (Right to Buy) | D | 29,84 | 20 000 | 20 000 | |||||
| 2020-02-06 | 3/A | Shah Rajeev M. | PHAT | Common Stock | I | 3 646 808 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-10-30 | 2019-10-29 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Convertible Promissory Notes | D | 0 | |||||||
| 2019-10-30 | 2019-10-29 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Common Stock | D | 19,0000 | 1 052 631 | 20 000 | 7 284 269 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Common Stock | D | 15,2000 | 1 353 640 | 20 575 | 6 231 638 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth Co-Invest I LP | PHAT | Convertible Promissory Notes | I | 15,20 | 0 | ||||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth I LP | PHAT | Convertible Promissory Notes | I | 15,20 | 0 | ||||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth Co-Invest I LP | PHAT | Common Stock | I | 19,0000 | 24 426 | 464 | 47 984 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth I LP | PHAT | Common Stock | I | 19,0000 | 1 028 205 | 19 536 | 2 019 877 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth Co-Invest I LP | PHAT | Common Stock | I | 15,2000 | 23 558 | 358 | 23 558 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth I LP | PHAT | Common Stock | I | 15,2000 | 991 672 | 15 073 | 991 672 | ||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Nabulsi Azmi | PHAT | Common Stock | D | 1 734 400 | ||||||||
| 2019-10-24 | 3 | Nabulsi Azmi | PHAT | Common Stock | D | 1 734 400 | ||||||||
| 2019-10-24 | 3 | Nabulsi Azmi | PHAT | Common Stock | D | 1 734 400 | ||||||||
| 2019-10-24 | 3 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 3 373 408 | ||||||||
| 2019-10-24 | 3 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 2 168 000 | ||||||||
| 2019-10-24 | 3 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 2 168 000 | ||||||||
| 2019-10-24 | 3 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 2 168 000 | ||||||||
| 2019-10-24 | 3 | Yamada Tadataka | PHAT | Common Stock | D | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Yamada Tadataka | PHAT | Common Stock | D | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Yamada Tadataka | PHAT | Common Stock | D | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Kohli Aditya | PHAT | Common Stock | D | 1 686 704 | ||||||||
| 2019-10-24 | 3 | Kohli Aditya | PHAT | Common Stock | D | 1 686 704 | ||||||||
| 2019-10-24 | 3 | Kohli Aditya | PHAT | Common Stock | D | 1 686 704 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
